boosters

AMA Update 108: Sandra Fryhofer, MD, discusses new J&J vaccine recommendations

AMA CXO Todd Unger talks with Sandra Fryhofer, MD, the AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and chair-elect of the AMA Board of Trustees about updated vaccine recommendations based on an increased, but still rare, risk of thrombosis with thrombocytopenia with the Johnson & Johnson vaccine. Also, covering the latest on Omicron and vaccine effectiveness, a vaccine safety update for children aged 5-11 and the status of a COVID vaccine for toddlers.

Read More

AMA Update 103: Andrea Garcia, JD, MPH, discusses omicron, vaccine mandate challenges and Merck’s COVID pill

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the omicron variant, vaccine mandate challenges and pending FDA authorization for Merck’s COVID pill.

Read More

AMA Update 101: Andrea Garcia, JD, MPH, discusses uptick in COVID cases and flu outbreaks

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on COVID-19 treatment pills, expanding eligibility for booster shots, what the uptick in cases in Europe could forecast for the U.S., as well as flu outbreaks and press releases from the November 2021 Special Meeting of the AMA House of Delegates.

Read More

AMA Update 99: Andrea Garcia, JD, MPH, discusses legal challenges to Biden’s vaccine requirements

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering legal challenges to the Biden administration’s recent vaccine requirements for large companies and health workers, as well as ongoing efforts to vaccinate the nation’s 5 to 11 year olds.

Read More

AMA Update 94: Dr. Sandra Fryhofer shares the latest on boosters and the new «mix-and-match strategy»

AMA CXO Todd Unger discusses what physicians need to know about boosters for Moderna, J&J recipients, and the newly approved mix-and-match strategy, with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

Read More

AMA Update 93: Andrea Garcia, JD, MPH, discusses boosters and pending authorizations

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster shots (including FDA and CDC recommendations), COVID case spikes related to dropping temperatures, and a reminder to get your annual flu shot.

Read More

AMA Update 87: Andrea Garcia, JD, MPH, discusses booster rollout, mask studies and this week’s numbers

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the booster roll out, mask studies in schools and the continued politicization of the pandemic.

Read More

AMA Update 86: Dr. Sandra Fryhofer shares what physicians need to know about boosters

AMA CXO Todd Unger talks boosters with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices. Learn what physicians need to know about the latest Pfizer booster authorization, including who is eligible, why boosters are needed and what this means for our larger efforts to fight the pandemic. 

Read More

AMA Update 64: Dr. Sandra Fryhofer discusses what physicians need to know about boosters, the Delta variant and immunocompromised patients

A discussion with Sandra Fryhofer, MD, chair-elect of the AMA Board of Trustees and the AMA’s liaison to the Advisory Committee on Immunization Practices, about if and when we’ll need COVID-19 vaccine boosters, the role of the dangerous Delta variant and how this all affects immunocompromised individuals.

Read More